Programmed death ligand 1 on Burkholderia pseudomallei-infected human polymorphonuclear neutrophils impairs T cell functions

Journal of Immunology

Volumn 194, Issue 9, 2015, Pages 4413-4421

  Buddhisa, Surachat ^a   Rinchai, Darawan ^a   Ato, Manabu ^b   Bancroft, Gregory J ^c   Lertmemongkolchai, Ganjana ^a  

^a KHON KAEN UNIVERSITY   (Thailand)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; MESSENGER RNA; PROGRAMMED DEATH 1 LIGAND 1; PROGRAMMED DEATH 1 RECEPTOR;

ARTICLE; BURKHOLDERIA PSEUDOMALLEI; CD4+ T LYMPHOCYTE; CELL INTERACTION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CORRELATIONAL STUDY; CYTOKINE PRODUCTION; HOST PATHOGEN INTERACTION; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; LYMPHOCYTE FUNCTION; MELIOIDOSIS; NEUTROPHIL; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RISK ASSESSMENT; UPREGULATION; ADULT; AGED; CELL COMMUNICATION; FEMALE; IMMUNOLOGY; IMMUNOMODULATION; MALE; METABOLISM; MICROBIOLOGY; MIDDLE AGED; SIGNAL TRANSDUCTION; T LYMPHOCYTE SUBPOPULATION;

ADULT; AGED; ANTIGENS, CD274; BURKHOLDERIA PSEUDOMALLEI; CD4-POSITIVE T-LYMPHOCYTES; CELL COMMUNICATION; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; IMMUNOMODULATION; MALE; MELIOIDOSIS; MIDDLE AGED; NEUTROPHILS; PROGRAMMED CELL DEATH 1 RECEPTOR; SIGNAL TRANSDUCTION; T-LYMPHOCYTE SUBSETS;

EID: 84928490922     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1402417     Document Type: Article

References (42)

1. Nathan, C. 2006. Neutrophils and immunity: challenges and opportunities. Nat. Rev. Immunol. 6: 173-182.
2. Tateda, K., T. A. Moore, J. C. Deng, M. W. Newstead, X. Zeng, A. Matsukawa, M. S. Swanson, K. Yamaguchi, and T. J. Standiford. 2001. Early recruitment of neutrophils determines subsequent T1/T2 host responses in a murine model of Legionella pneumophila pneumonia. J. Immunol. 166: 3355-3361.
3. Thewissen, M., J. Damoiseaux, J. van de Gaar, and J. W. Tervaert. 2011. Neutrophils and T cells: bidirectional effects and functional interferences. Mol. Immunol. 48: 2094-2101.
4. Pelletier, M., L. Maggi, A. Micheletti, E. Lazzeri, N. Tamassia, C. Costantini, L. Cosmi, C. Lunardi, F. Annunziato, S. Romagnani, and M. A. Cassatella. 2010. Evidence for a cross-talk between human neutrophils and Th17 cells. Blood 115: 335-343.
5. Chertov, O., H. Ueda, L. L. Xu, K. Tani, W. J. Murphy, J. M. Wang, O. M. Howard, T. J. Sayers, and J. J. Oppenheim. 1997. Identification of human neutrophil-derived cathepsin G and azurocidin/CAP37 as chemoattractants for mononuclear cells and neutrophils. J. Exp. Med. 186: 739-747.
6. Müller, I., M. Munder, P. Kropf, and G. M. Hänsch. 2009. Polymorphonuclear neutrophils and T lymphocytes: strange bedfellows or brothers in arms? Trends Immunol. 30: 522-530.
7. Hock, B. D., K. G. Taylor, N. B. Cross, A. J. Kettle, M. B. Hampton, and J. L. McKenzie. 2012. Effect of activated human polymorphonuclear leucocytes on T lymphocyte proliferation and viability. Immunology 137: 249-258.
8. Pillay, J., V. M. Kamp, E. van Hoffen, T. Visser, T. Tak, J. W. Lammers, L. H. Ulfman, L. P. Leenen, P. Pickkers, and L. Koenderman. 2012. A subset of neutrophils in human systemic inflammation inhibits T cell responses through Mac-1. J. Clin. Invest. 122: 327-336.
9. Schmielau, J., and O. J. Finn. 2001. Activated granulocytes and granulocyte-derived hydrogen peroxide are the underlying mechanism of suppression of t-cell function in advanced cancer patients. Cancer Res. 61: 4756-4760.
10. Cheng, A. C., and B. J. Currie. 2005. Melioidosis: epidemiology, pathophysiology, and management. [Published erratum appears in 2007 Clin. Microbiol. Rev. 20: 533.] Clin. Microbiol. Rev. 18: 383-416.
11. Wiersinga, W. J., T. van der Poll, N. J. White, N. P. Day, and S. J. Peacock. 2006. Melioidosis: insights into the pathogenicity of Burkholderia pseudomallei. Nat. Rev. Microbiol. 4: 272-282.
12. Limmathurotsakul, D., W. Chaowagul, W. Chierakul, K. Stepniewska, B. Maharjan, V. Wuthiekanun, N. J. White, N. P. Day, and S. J. Peacock. 2006. Risk factors for recurrent melioidosis in northeast Thailand. Clin. Infect. Dis. 43: 979-986.
13. Easton, A., A. Haque, K. Chu, R. Lukaszewski, and G. J. Bancroft. 2007. A critical role for neutrophils in resistance to experimental infection with Burkholderia pseudomallei. J. Infect. Dis. 195: 99-107.
14. Haque, A., K. Chu, A. Easton, M. P. Stevens, E. E. Galyov, T. Atkins, R. Titball, and G. J. Bancroft. 2006. A live experimental vaccine against Burkholderia pseudomallei elicits CD4+ T cell-mediated immunity, priming T cells specific for 2 type III secretion system proteins. J. Infect. Dis. 194: 1241-1248.
15. Santanirand, P., V. S. Harley, D. A. Dance, B. S. Drasar, and G. J. Bancroft. 1999. Obligatory role of gamma interferon for host survival in a murine model of infection with Burkholderia pseudomallei. Infect. Immun. 67: 3593-3600.
16. Tippayawat, P., W. Saenwongsa, J. Mahawantung, D. Suwannasaen, P. Chetchotisakd, D. Limmathurotsakul, S. J. Peacock, P. L. Felgner, H. S. Atkins, R. W. Titball, et al. 2009. Phenotypic and functional characterization of human memory T cell responses to Burkholderia pseudomallei. PLoS Negl. Trop. Dis. 3. Available at: http://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0000407.
17. Pankla, R., S. Buddhisa, M. Berry, D. M. Blankenship, G. J. Bancroft, J. Banchereau, G. Lertmemongkolchai, and D. Chaussabel. 2009. Genomic transcriptional profiling identifies a candidate blood biomarker signature for the diagnosis of septicemic melioidosis. Genome Biol. 10: R127.
18. Jurado, J. O., I. B. Alvarez, V. Pasquinelli, G. J. Martïnez, M. F. Quiroga, E. Abbate, R. M. Musella, H. E. Chuluyan, and V. E. García. 2008. Programmed death (PD)-1:PD-ligand 1/PD-ligand 2 pathway inhibits T cell effector functions during human tuberculosis. J. Immunol. 181: 116-125.
19. Freeman, G. J., A. J. Long, Y. Iwai, K. Bourque, T. Chernova, H. Nishimura, L. J. Fitz, N. Malenkovich, T. Okazaki, M. C. Byrne, et al. 2000. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J. Exp. Med. 192: 1027-1034.
20. Keir, M. E., M. J. Butte, G. J. Freeman, and A. H. Sharpe. 2008. PD-1 and its ligands in tolerance and immunity. Annu. Rev. Immunol. 26: 677-704.
21. Bowers, N. L., E. S. Helton, R. P. Huijbregts, P. A. Goepfert, S. L. Heath, and Z. Hel. 2014. Immune suppression by neutrophils in HIV-1 infection: role of PD-L1/PD-1 pathway. PLoS Pathog. 10. Available at: http://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1003993.
22. Huang, X., F. Venet, Y. L. Wang, A. Lepape, Z. Yuan, Y. Chen, R. Swan, H. Kherouf, G. Monneret, C. S. Chung, and A. Ayala. 2009. PD-1 expression by macrophages plays a pathologic role in altering microbial clearance and the innate inflammatory response to sepsis. Proc. Natl. Acad. Sci. USA 106: 6303-6308.
23. Brahmamdam, P., S. Inoue, J. Unsinger, K. C. Chang, J. E. McDunn, and R. S. Hotchkiss. 2010. Delayed administration of anti-PD-1 antibody reverses immune dysfunction and improves survival during sepsis. J. Leukoc. Biol. 88: 233-240.
24. Zhang, Y., Y. Zhou, J. Lou, J. Li, L. Bo, K. Zhu, X. Wan, X. Deng, and Z. Cai. 2010. PD-L1 blockade improves survival in experimental sepsis by inhibiting lymphocyte apoptosis and reversing monocyte dysfunction. Crit. Care 14: R220.
25. McNab, F. W., M. P. Berry, C. M. Graham, S. A. Bloch, T. Oni, K. A. Wilkinson, R. J. Wilkinson, O. M. Kon, J. Banchereau, D. Chaussabel, and A. O'Garra. 2011. Programmed death ligand 1 is over-expressed by neutrophils in the blood of patients with active tuberculosis. Eur. J. Immunol. 41: 1941-1947.
26. de Kleijn, S., J. D. Langereis, J. Leentjens, M. Kox, M. G. Netea, L. Koenderman, G. Ferwerda, P. Pickkers, and P. W. Hermans. 2013. IFN-γ-stimulated neutrophils suppress lymphocyte proliferation through expression of PD-L1. PLoS ONE 8. Available at: http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0072249#pone-0072249-g004.
27. Bone, R. C., R. A. Balk, F. B. Cerra, R. P. Dellinger, A. M. Fein, W. A. Knaus, R. M. Schein, and W. J. Sibbald, The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. 1992. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 101: 1644-1655.
28. Chanchamroen, S., C. Kewcharoenwong, W. Susaengrat, M. Ato, and G. Lertmemongkolchai. 2009. Human polymorphonuclear neutrophil responses to Burkholderia pseudomallei in healthy and diabetic subjects. Infect. Immun. 77: 456-463.
29. Holden, M. T., R. W. Titball, S. J. Peacock, A. M. Cerdeño-Tárraga, T. Atkins, L. C. Crossman, T. Pitt, C. Churcher, K. Mungall, S. D. Bentley, et al. 2004. Genomic plasticity of the causative agent of melioidosis, Burkholderia pseudomallei. Proc. Natl. Acad. Sci. USA 101: 14240-14245.
30. Youn, J. I., S. Nagaraj, M. Collazo, and D. I. Gabrilovich. 2008. Subsets of myeloid-derived suppressor cells in tumor-bearing mice. J. Immunol. 181: 5791-5802.
31. Klemke, M., G. H. Wabnitz, F. Funke, B. Funk, H. Kirchgessner, and Y. Samstag. 2008. Oxidation of cofilin mediates T cell hyporesponsiveness under oxidative stress conditions. Immunity 29: 404-413.
32. Schoonbroodt, S., V. Ferreira, M. Best-Belpomme, J. R. Boelaert, S. Legrand-Poels, M. Korner, and J. Piette. 2000. Crucial role of the amino-terminal tyrosine residue 42 and the carboxyl-terminal PEST domain of I kappa B alpha in NF-kappa B activation by an oxidative stress. J. Immunol. 164: 4292-4300.
33. Yang, C. W., B. S. Strong, M. J. Miller, and E. R. Unanue. 2010. Neutrophils influence the level of antigen presentation during the immune response to protein antigens in adjuvants. J. Immunol. 185: 2927-2934.
34. Sarkar-Tyson, M., J. E. Thwaite, S. V. Harding, S. J. Smither, P. C. Oyston, T. P. Atkins, and R. W. Titball. 2007. Polysaccharides and virulence of Burkholderia pseudomallei. J. Med. Microbiol. 56: 1005-1010.
35. Rinchai, D., P. Khaenam, C. Kewcharoenwong, S. Buddhisa, R. Pankla, D. Chaussabel, G. J. Bancroft, and G. Lertmemongkolchai. 2012. Production of interleukin-27 by human neutrophils regulates their function during bacterial infection. Eur. J. Immunol. 42: 3280-3290.
36. Hirahara, K., K. Ghoreschi, X. P. Yang, H. Takahashi, A. Laurence, G. Vahedi, G. Sciumè, A. O. Hall, C. D. Dupont, L. M. Francisco, et al. 2012. Interleukin-27 priming of T cells controls IL-17 production in trans via induction of the ligand PD-L1. Immunity 36: 1017-1030.
37. Brown, K. E., G. J. Freeman, E. J. Wherry, and A. H. Sharpe. 2010. Role of PD-1 in regulating acute infections. Curr. Opin. Immunol. 22: 397-401.
38. Barber, D. L., E. J. Wherry, D. Masopust, B. Zhu, J. P. Allison, A. H. Sharpe, G. J. Freeman, and R. Ahmed. 2006. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439: 682-687.
39. Muller, L. M., K. J. Gorter, E. Hak, W. L. Goudzwaard, F. G. Schellevis, A. I. Hoepelman, and G. E. Rutten. 2005. Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus. Clin. Infect. Dis. 41: 281-288.
40. Kewcharoenwong, C., D. Rinchai, K. Utispan, D. Suwannasaen, G. J. Bancroft, M. Ato, and G. Lertmemongkolchai. 2013. Glibenclamide reduces proinflammatory cytokine production by neutrophils of diabetes patients in response to bacterial infection. Sci Rep 3: 3363.
41. Tan, K. S., K. O. Lee, K. C. Low, A. M. Gamage, Y. Liu, G. Y. Tan, H. Q. Koh, S. Alonso, and Y. H. Gan. 2012. Glutathione deficiency in type 2 diabetes impairs cytokine responses and control of intracellular bacteria. J. Clin. Invest. 122: 2289-2300.
42. Koh, G. C., R. R. Maude, M. F. Schreiber, D. Limmathurotsakul, W. J. Wiersinga, V. Wuthiekanun, S. J. Lee, W. Mahavanakul, W. Chaowagul, W. Chierakul, et al. 2011. Glyburide is anti-inflammatory and associated with reduced mortality in melioidosis. Clin. Infect. Dis. 52: 717-725.